Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 0 | 0 | 0 | 0 | 86 |
| Gross Profit | N/A | N/A | N/A | N/A | 86 |
| Operating Expenses | 35,252 | 36,770 | 52,063 | 34,320 | 40,484 |
| Operating Income | -35,252 | -36,770 | -52,063 | -34,320 | -40,398 |
| Other Income | 216 | -539 | 726 | 1,376 | 487 |
| Pre-tax Income | -35,036 | -37,309 | -51,337 | -32,944 | -39,911 |
| Net Income Continuous | -35,036 | -37,309 | -51,337 | -32,944 | -39,911 |
| Net Income | $-35,036 | $-37,309 | $-51,337 | $-32,944 | $-39,911 |
| EPS Basic Total Ops | -0.82 | -0.95 | -1.90 | -1.50 | -2.61 |
| EPS Basic Continuous Ops | -0.82 | -0.95 | -1.90 | -1.50 | -2.61 |
| EPS Diluted Total Ops | -0.82 | -0.95 | -1.90 | -1.50 | -2.61 |
| EPS Diluted Continuous Ops | -0.82 | -0.95 | -1.90 | -1.50 | -2.61 |
| EPS Diluted Before Non-Recurring Items | -0.82 | -0.95 | -1.90 | -1.50 | -2.61 |
| EBITDA(a) | $-35,032 | $-36,523 | $-51,856 | $-34,186 | $-40,298 |